GSE146687 irinotecan 2 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146687_irinotecan_2_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146687_irinotecan_2_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146687_irinotecan_2_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146687_irinotecan_2_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

non-SMC condensin I complex subunit D2 pseudogene 1

Gene

vomeronasal 1 receptor 110 pseudogene

Gene

C1QTNF7 antisense RNA 1

Gene

RNA, 7SL, cytoplasmic 301, pseudogene

Gene

FAM174A divergent transcript

Gene

transportin 1 pseudogene 2

Gene

EWSR1 pseudogene 2

Gene

long intergenic non-protein coding RNA 1495

Gene

ribosomal protein S7 pseudogene 12

Gene

nucleophosmin 1 pseudogene 36

  • Gene

    non-SMC condensin I complex subunit D2 pseudogene 1


  • Gene

    vomeronasal 1 receptor 110 pseudogene


  • Gene

    C1QTNF7 antisense RNA 1


  • Gene

    RNA, 7SL, cytoplasmic 301, pseudogene


  • Gene

    FAM174A divergent transcript


  • Gene

    transportin 1 pseudogene 2


  • Gene

    EWSR1 pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 1495


  • Gene

    ribosomal protein S7 pseudogene 12


  • Gene

    nucleophosmin 1 pseudogene 36

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.